HR Digest

NOVEMBER 10, 2021

Ramcess Jean-Loiuis, Pfizer’s Chief Diversity, Equity & Inclusion (DEI) Officer, is not short on ambition. Having joined the world’s largest pharmaceutical company, she is now out to raise the bar for human resources leadership across the organization. The HR Digest: What is diversity to you? ? . and authentic self.??At

Diversity 102

Diversity Commitment Learning-by-Doing Globalization 102

The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity.

Diversity 113

Diversity Innovation Biotechnology Short-term 113

Great Leadership By Dan

MAY 22, 2014

That is, it helps to believe you''re better than you are, and be more optimistic about your company and business, than an entirely objective analysis would warrant. It''s important to be aware of these blindspots because they expose you and your company to a variety of risks. Seek Out Disconfirming Data. Robert holds a Ph.D.

Shaw 229

Shaw Telecommunications Metrics Pharmaceuticals 229

Marshall Goldsmith

OCTOBER 6, 2014

So, why do most companies go about picking their next generation mired in the past? The truth is that companies that only choose wise, experienced people for this task of succession are mired in myopia. It is a company looking into the future like a horse with blinders. Appreciating Cultural Diversity. Think about it.

Leadership 189

Leadership Globalization CEO Telecommunications 189

HR Digest

OCTOBER 21, 2019

California’s Assembly Bill 5 (“AB-5”) that radically alters the definition of an “employee” so that companies can no longer misclassify would-be employees as independent contractors. The bill will limit the amount of independent contract work a California-based company can claim. Officially known as Dynamex Operations West, Inc.

Pharmaceuticals 64

Pharmaceuticals Industry Letter Insurance 64

Engaging Leader

APRIL 13, 2014

Provisions of employer-sponsored health care coverage that influence how health care services and pharmaceuticals are selected, purchased, and used. Terry has over 25 years of experience helping companies communicate effectively with their employees. that optimize health outcomes and cost-effectiveness. Benefit Plan Design.

Health Care 138

Health Care Pharmaceuticals Long-term Education 138

Tanveer Naseer

MARCH 10, 2015

What most companies understand now is that the only way to drive profitable growth and wealth creation over the longer term is to innovate. In my new book “ The 4 Lenses of Innovation ”, I outline four proven ways to generate the new strategic opportunities that will power your company’s future growth. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

HR Digest

AUGUST 22, 2023

Recent reports suggest that Eli Lilly, a prominent pharmaceutical manufacturer, has been embroiled in a class-action lawsuit alleging discriminatory hiring practices against older job applicants. They argued that the company favored younger applicants, despite their equal or superior qualifications for the job.

Pharmaceuticals 52

Pharmaceuticals Survey Diversity Policies 52

Marshall Goldsmith

FEBRUARY 8, 2018

They represent leaders in their own worlds with a diversity of interests that relate to the topic of coaching. US News and World Report #1 Best Hospital in the United States – Fortune ‘100 Best Companies to Work For,’ 14 consecutive years. Garry Ridge – CEO, WD-40 Company. It is time now to announce the 100 Coaches.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Strategy Driven

JUNE 22, 2018

Shares in companies that supply products for seniors have a very healthy return – the health sector, pharmaceuticals, and even the leisure industry have been boosted by the change in demographics. You want your campaign to be inclusive and not something that restricts the idea of diversity. Bilingual Consumers.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Harvard Business Review

OCTOBER 25, 2018

The debate about superstar firms and superstar effects has been intensifying, partly in response to the rapid growth of global US tech companies. They come from all regions and sectors and include global banks and manufacturing companies, long-standing Western consumer brands, and fast-growing U.S. Apexphotos/Getty Images.

Industry 12

Industry Company GDP Bottom-up 12

Center for Creative Leadership

AUGUST 26, 2019

Our series of industry trend research reports — created using our flagship 360-assessment tool, Benchmarks® for Managers — shows that great similarities exist among leaders across industries including healthcare, pharmaceutical, financial, tech, energy, and government (civilian).

Benchmarking 57

Benchmarking Leadership Bottom-up Leadership Pipeline 57

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. “This seems like pie-in-the-sky wishful thinking. But it does happen.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

JUNE 20, 2017

Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication. But those procedures had also slowed the company down. Reddy’s: A Movement-Minded Case Study. One leader who understands this well is G.V. He was proudly stating that!

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

MARCH 14, 2017

We believe these same measures can be successfully adopted and adapted by other companies in pharma and other sectors that seek to avert, or reverse, innovation stagnation. In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers.

Innovation 9

Innovation Company Incentives Industry 9

Harvard Business Review

OCTOBER 23, 2017

The companies best positioned to change in the next decade will be the ones that set themselves up well now, by collecting the right kind of data and investing in their analytics capacity. The key to building predictive models is knowing what you want to predict and collecting large and diverse data sets that may enable you to do so.

Company 8

Company Management Metrics Tools 8

Harvard Business Review

JULY 14, 2017

presidential election, Interpublic (IPG), my company’s parent corporation, held its first open call for employees to talk about concerns related to respect in the workplace. ” Companies today have the capacity to be a haven from the incivility that individuals confront every day, on the road, online, in the media, and in politics.

Diversity 9

Diversity Politics Survey Incubator 9

Harvard Business Review

MARCH 6, 2015

Why is it that some companies experience tremendous success abroad, while others struggle to go global? In my work as a global business advisor to Fortune 500 companies and high-tech start-ups, I’ve observed seven traits that distinguish companies with accelerated global growth. They have an innate global bias.

Company 8

Company Globalization Software Wireless 8

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. The hope was that the diversity of brainpower and perspectives would yield imaginative ways to outgrow the shortfall. This kind of approach to special challenges that companies face is new.

Leadership 10

Leadership Diversity Committee Long-term 10

Harvard Business Review

OCTOBER 18, 2012

That's the blunt response from one African-American executive to a dilemma that dogs many people of color in American workplaces: Even as multicultural fluency is increasingly prized in today's global business environment, the very people who represent that diversity feel shut out.

Diversity 16

Diversity Pharmaceuticals Uncertainty Focus Group 16

Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Strategy Driven

MARCH 18, 2011

The conventional wisdom about strategy may be leading your company astray. Achieving coherence requires a sharpness of focus that few companies have mastered. In this unpredictable economy, traditional approaches to strategy are a luxury most companies cannot afford. by Paul Leinwand and Cesare Mainardi. Let’s go after it.”

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

JUNE 21, 2013

Given the forecasts of uncertain global economic growth, we might expect companies to hold off from hiring new employees and to limit whatever international hiring they do to emerging markets. The vast majority of board members told us their companies are hiring in double-digits and across the globe. Are you and your company ready?

Telecommunications 9

Telecommunications Health Care Talent Management Biotechnology 9

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. Some 15 years ago my colleague Sumantra Ghoshal and I wrote business cases on three companies that were then leaders in their sectors: BP, Royal Bank of Scotland, and Nokia.

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

MAY 22, 2018

As a professional speaker who delivers between 30-50 paid keynotes per year, here are three strategies I’ve discovered that can help you craft a successful talk that resonates with diverse attendees. First, it can be helpful to envision the sections of your speech as “modules” that you can shift and reshuffle as needed.

Audience 9

Audience How To Pharmaceuticals Conference 9

Harvard Business Review

SEPTEMBER 21, 2018

Fewer than one-third (30%) of respondents to our survey see innovation as one of the top three challenges their company faces in achieving its strategic objectives, and just 21% think that technology trends are a major strategic challenge. We found that concerns about innovation fall behind other issues for most directors.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

NOVEMBER 24, 2016

At this point, we all know that company culture plays a pivotal role in companies hurtling into out digital transformations. This year, I have been working on an in-depth evaluation of recruiting practices for a Fortune 500 company. Compete for talent the way companies compete for customers.

Marketing 8

Marketing Content Pharmaceuticals PR 8

Harvard Business Review

MARCH 16, 2015

This was especially daunting during periods of change or growth in which companies needed to hire in large numbers. ” Once companies hired new talent, new challenges arose, such as how these employees represented the company. ” Some CEOs worried about setting direction and tone for the company across regions.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

JANUARY 31, 2013

The new era will give manufacturing companies an opportunity to help their host economies in all of those areas; it will create high-skill jobs, particularly in design, big data, and other service roles, but not masses of production-line positions. On the innovation front, the opportunities are more diverse, but equally powerful.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Merck and Co. Integration is key.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

NOVEMBER 8, 2017

The rising flood of hardware, pharmaceuticals, and technical expertise from American manufacturers and hospital companies, which is connected to the needs of a growing number of hospitals, is also pushing many systems closer to the U.S. Over the same period, pharmaceutical exports have doubled. Transforming Health Care.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

JULY 30, 2015

A new research report from the Society of Digital Agencies finds that in the past year there has been a dramatic spike in the number of companies who no longer work with outside marketing agencies — 27 percent, up from 13 percent in the previous year. Companies no longer want to outsource customer relationships. ” 2. .

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

JULY 16, 2013

Both paths are problematic — neither is particularly transparent or relies on objective measures and given that many boards are stubborn bastions of white masculinity, pursuing the "right" network can be fraught, especially for women and other diverse candidates. banking & financial services, insurance, real estate); Health Care (e.g.,

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

MARCH 9, 2015

Salesforce.com CEO Marc Benioff actively participates in conversation threads in order to stir the pot and keep current on the ways programmers and customers test the limits of his company’s products. For example, a study of a multinational pharmaceutical company revealed that leaders in its U.S.

Tools 8

Tools CEO Mezzanine Software 8